Program 80 mg Suspension for Injection for Cats
Program 80 mg Suspension for Injection for Cats
Not authorised
- Lufenuron
Product identification
Medicine name:
Program 80 mg Suspension for Injection for Cats
Program 80 mg Suspension zur Injektion für Katzen
Active substance:
- Lufenuron
Target species:
-
Cat
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Lufenuron80.00milligram(s)0.80millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP53BC01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Austria
Package description:
- Available only in German
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Elanco France S.A.S.
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 8-00352
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0422/002
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Labelling
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 3/08/2023
Updated on: 14/03/2025
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 3/08/2023
Updated on: 14/03/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 3/08/2023
Updated on: 14/03/2025
How useful was this page?: